radiopharmaceutical

Siemens Healthineers Molecular Imaging has formed a research collaboration with Massachusetts General Hospital (MGH) to advance the use of theranostics. The ability to diagnose disease with one radiopharmaceutical and treat it with a similar therapeutic agent, theranostics has been used to treat certain types of cancer, including thyroid cancer, prostate